C3bot peptides as drugs for the treatment of traumatic or degenerative neuronal injury
Peptide fragments of the C3 exoenzyme of Clostridium botulinum have been found to have neuritogenic effects on neurons as well as regenerative properties in an animal model (mouse). The peptides represent promising drug candidates for the treatment of neurodegenerative disorders such as Morbus Alzheimer, Parkinson, Huntington chorea but also for spinal cord injury and traumatic brain injury.
Further Information: PDF
ipal GmbH
Phone: +49 (0)30/2125-4820
Contact
Dr. Dirk Dantz
Media Contact
All latest news from the category: Technology Offerings
Newest articles
AI to improve brain cancer diagnosis, monitoring, treatment
Recommendations published in The Lancet Oncology call for good clinical practice of new technologies to modernize decades-old standard of care for brain cancer patients. An international, multidisciplinary team of leading…
AI tool ‘sees’ cancer gene signatures in biopsy images
AI tool reads biopsy images… To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a microscope. But to figure out…
Skull bone marrow expands throughout life
…and remains healthy during aging. Blood vessels and stromal cells in the bone marrow create an ideal environment for hematopoietic stem cells to continuously produce all blood cells. During aging,…